291 related articles for article (PubMed ID: 14882450)
1. The effect of BAL (2,3-dimercaptopropanol) on hepatolenticular degeneration (Wilson's disease).
DENNY-BROWN D; PORTER H
N Engl J Med; 1951 Dec; 245(24):917-25. PubMed ID: 14882450
[No Abstract] [Full Text] [Related]
2. The effect of BAL (2,3-dimercaptopropanol) on hepatolenticular degeneration (Wilson's disease).
DENNY-BROWN D; PORTER H
Trans Am Neurol Assoc; 1951; 56():79-84. PubMed ID: 14913592
[No Abstract] [Full Text] [Related]
3. [BAL (2, 3-dimercaptopropanol) therapy of hepatolenticular degeneration].
BOZHINOV S
Suvr Med (Sofiia); 1955; 6(7):96-100. PubMed ID: 13299060
[No Abstract] [Full Text] [Related]
4. Dimercaprol in the pre-neurological stage of Wilson's disease (hepatolenticular degeneration).
WARNOCK CG; NEILL DW
J Neurol Neurosurg Psychiatry; 1954 Feb; 17(1):70-4. PubMed ID: 13131080
[No Abstract] [Full Text] [Related]
5. Penicillamine, a new oral therapy for Wilson's disease.
WALSHE JM
Am J Med; 1956 Oct; 21(4):487-95. PubMed ID: 13362281
[No Abstract] [Full Text] [Related]
6. DIMERCAPROL for hepatolenticular degeneration.
Lancet; 1952 Jan; 1(6700):199-200. PubMed ID: 14889814
[No Abstract] [Full Text] [Related]
7. Hepatolenticular degeneration; review of the literature and report of a case with dimercaprol (BAL) therapy.
SCHECHTER MM; JONES CA
AMA Arch Intern Med; 1953 Apr; 91(4):541-9. PubMed ID: 13039608
[No Abstract] [Full Text] [Related]
8. [On BAL treatment of hepatolenticular degeneration].
KNUPPEL H
Med Klin; 1956 Jan; 51(3):107-8. PubMed ID: 13296803
[No Abstract] [Full Text] [Related]
9. Effect of dimercaprol (BAL) in hepatolenticular degeneration; report of a case, with clinical and electroencephalographic study.
STREIFLER M; FELDMAN S
AMA Arch Neurol Psychiatry; 1953 Jan; 69(1):84-90. PubMed ID: 12996137
[No Abstract] [Full Text] [Related]
10. [Case of hepatolenticular degeneration treated by BAL].
DRABKOWSKA AM
Neurol Neurochir Psychiatr Pol; 1956; 6(5):541-7. PubMed ID: 13407808
[No Abstract] [Full Text] [Related]
11. [Biochemistry of hepatolenticular degeneration; its treatment with BAL].
BONDUELLE M; HARL JM
Bull Med; 1953 Jun; 67(12):333-5. PubMed ID: 13082329
[No Abstract] [Full Text] [Related]
12. Hepatolenticular degeneration; follow-up report of a case treated with dimercaprol (BAL), potassium sulfide, and high-protein diet.
FERRISS GS; BERRY S
AMA Arch Intern Med; 1957 Apr; 99(4):656-9. PubMed ID: 13410170
[No Abstract] [Full Text] [Related]
13. Tissue copper determinations in a case of hepatolenticular degeneration treated with BAL (dimercaprol).
PALMER JF; DREW AL; CHENOWETH MB
Med Bull (Ann Arbor); 1953 Nov; 19(11):308-11. PubMed ID: 13122933
[No Abstract] [Full Text] [Related]
14. [BAL therapy of hepatolenticular degeneration].
CAROIT M
Sem Hop; 1955 May; 31(28):1625-6. PubMed ID: 14385888
[No Abstract] [Full Text] [Related]
15. Denny-Brown, Wilson's disease, and BAL (British antilewisite [2,3-dimercaptopropanol]).
Vilensky JA; Robertson WM; Gilman S
Neurology; 2002 Sep; 59(6):914-6. PubMed ID: 12297577
[TBL] [Abstract][Full Text] [Related]
16. [BAL therapy and copper excretion in hepatolenticular syndrome].
ERDMANN-MULLER GJ; HORNBOSTEL H
Klin Wochenschr; 1953 Dec; 31(45-46):1102-3. PubMed ID: 13118699
[No Abstract] [Full Text] [Related]
17. Hepatolenticular degeneration; clinical and pathological report of a case treated with BAL.
RASKIN N; MACKENZIE JM
J Nerv Ment Dis; 1954; 120(3-4):176-83. PubMed ID: 13233959
[No Abstract] [Full Text] [Related]
18. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine].
D'Addabbo A; Damato VD; Germinario L; Campanella G; Boccuni N
Acta Neurol (Napoli); 1971; 26(4):436-48. PubMed ID: 5132825
[No Abstract] [Full Text] [Related]
19. [Hepatolenticular degeneration or Wilson's disease. Results of treatment].
Concours Med; 1965 Apr; 87(17):2941-6. PubMed ID: 5317932
[No Abstract] [Full Text] [Related]
20. Introduction. Symposium on copper metabolism and Wilson's disease.
Goldstein NP; Owen CA
Mayo Clin Proc; 1974 Jun; 49(6):363-7. PubMed ID: 4599351
[No Abstract] [Full Text] [Related]
[Next] [New Search]
